secwatch / observer
8-K filed March 27, 2026, 7:59 PM ET ticker STOK CIK 0001623526
other material confidence high sentiment neutral materiality 0.60

Stoke Therapeutics, Inc. (STOK): auditor change — Stoke Therapeutics dismisses KPMG, appoints Ernst & Young as auditor

Stoke Therapeutics, Inc.

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.99

Stoke Therapeutics, Inc. engaged Ernst & Young LLP as its auditor.

Action
engagement
Auditor
Ernst & Young LLP
Exact text from the filing
On March 23, 2026, the Audit Committee approved the engagement of Ernst & Young LLP (“EY”) as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.
View on SEC.gov
Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.99

Stoke Therapeutics, Inc. dismissed KPMG LLP as its auditor.

Action
dismissal
Auditor
KPMG LLP
Exact text from the filing
On March 23, 2026, the Audit Committee (the “Audit Committee”) of the Board of Directors of Stoke Therapeutics, Inc. (the “Company”) dismissed KPMG LLP (“KPMG”) as the Company’s independent registered public accounting firm.
View on SEC.gov

Browse all auditor changes →

Stoke Therapeutics, Inc. filing history →

Source: SEC EDGAR
accession 0001193125-26-129168
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.